ITRM vs PSA · rev $390.0K vs rev $4.82B
Iterum Therapeutics PLC (ITRM) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
PSA (PSA) common stock.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
ITRM currently screens at market cap $38.6M. PSA currently screens at market cap $0.
Not investment advice. Open the ITRM and PSA stock pages for the full models.
Not investment advice.